| James C Lee, DPM | |
|
5475 E La Palma Ave, Ste 208, Anaheim, CA 92807-6009 | |
| (714) 777-0750 | |
| (714) 777-8291 |
| Full Name | James C Lee |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 31 Years |
| Location | 5475 E La Palma Ave, Anaheim, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437253663 | NPI | - | NPPES |
| 000E39630 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | 213EG0000X (California) | Secondary |
| 213E00000X | Podiatrist | E3963 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Jude Medical Center | Fullerton, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Providence Medical Foundation | 8921993205 | 1293 |
News Archive
Merck & Co., Inc. today announced financial results for the first quarter of 2010. The company reported non-GAAP (generally accepted accounting principles) earnings per share (EPS) for the first quarter of $0.83, which excludes purchase accounting adjustments, merger-related expenses and restructuring costs, as well as a tax charge related to the recently enacted health care reform legislation. First-quarter GAAP EPS was $0.09.
Approximately $500,000 is available in federal American Recovery and Reinvestment Act funds to support a specialized training curriculum on the Mental Health Procedures Act of 1976 for judges, law enforcement, psychologists, social workers and other professionals in the criminal justice system.
Z-Medica Corporation, a medical device company developing innovative hemostatic agents, today announced that it has signed exclusive distribution agreements with Vingmed AB and Mediplast AB, two leading Swedish medical device distributors, for distribution of its QuikClot line of hemostatic agents in Sweden, Denmark and Norway for the first time.
Researchers from the University of Copenhagen have discovered a way of improving biotech drugs. Better, cheaper and more effective drugs to combat cancer, arthritis and many other disorders.
› Verified 3 days ago
| Provider Name | Providence Medical Foundation |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1285890624 PECOS PAC ID: 8921993205 Enrollment ID: O20040216001346 |
News Archive
Merck & Co., Inc. today announced financial results for the first quarter of 2010. The company reported non-GAAP (generally accepted accounting principles) earnings per share (EPS) for the first quarter of $0.83, which excludes purchase accounting adjustments, merger-related expenses and restructuring costs, as well as a tax charge related to the recently enacted health care reform legislation. First-quarter GAAP EPS was $0.09.
Approximately $500,000 is available in federal American Recovery and Reinvestment Act funds to support a specialized training curriculum on the Mental Health Procedures Act of 1976 for judges, law enforcement, psychologists, social workers and other professionals in the criminal justice system.
Z-Medica Corporation, a medical device company developing innovative hemostatic agents, today announced that it has signed exclusive distribution agreements with Vingmed AB and Mediplast AB, two leading Swedish medical device distributors, for distribution of its QuikClot line of hemostatic agents in Sweden, Denmark and Norway for the first time.
Researchers from the University of Copenhagen have discovered a way of improving biotech drugs. Better, cheaper and more effective drugs to combat cancer, arthritis and many other disorders.
› Verified 3 days ago
| Provider Name | Pioneer Medical Group Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1548303589 PECOS PAC ID: 1759317696 Enrollment ID: O20050712001246 |
News Archive
Merck & Co., Inc. today announced financial results for the first quarter of 2010. The company reported non-GAAP (generally accepted accounting principles) earnings per share (EPS) for the first quarter of $0.83, which excludes purchase accounting adjustments, merger-related expenses and restructuring costs, as well as a tax charge related to the recently enacted health care reform legislation. First-quarter GAAP EPS was $0.09.
Approximately $500,000 is available in federal American Recovery and Reinvestment Act funds to support a specialized training curriculum on the Mental Health Procedures Act of 1976 for judges, law enforcement, psychologists, social workers and other professionals in the criminal justice system.
Z-Medica Corporation, a medical device company developing innovative hemostatic agents, today announced that it has signed exclusive distribution agreements with Vingmed AB and Mediplast AB, two leading Swedish medical device distributors, for distribution of its QuikClot line of hemostatic agents in Sweden, Denmark and Norway for the first time.
Researchers from the University of Copenhagen have discovered a way of improving biotech drugs. Better, cheaper and more effective drugs to combat cancer, arthritis and many other disorders.
› Verified 3 days ago
| Provider Name | James C. Lee, Dpm A Professional Corp |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1376926808 PECOS PAC ID: 3678883857 Enrollment ID: O20151102000016 |
News Archive
Merck & Co., Inc. today announced financial results for the first quarter of 2010. The company reported non-GAAP (generally accepted accounting principles) earnings per share (EPS) for the first quarter of $0.83, which excludes purchase accounting adjustments, merger-related expenses and restructuring costs, as well as a tax charge related to the recently enacted health care reform legislation. First-quarter GAAP EPS was $0.09.
Approximately $500,000 is available in federal American Recovery and Reinvestment Act funds to support a specialized training curriculum on the Mental Health Procedures Act of 1976 for judges, law enforcement, psychologists, social workers and other professionals in the criminal justice system.
Z-Medica Corporation, a medical device company developing innovative hemostatic agents, today announced that it has signed exclusive distribution agreements with Vingmed AB and Mediplast AB, two leading Swedish medical device distributors, for distribution of its QuikClot line of hemostatic agents in Sweden, Denmark and Norway for the first time.
Researchers from the University of Copenhagen have discovered a way of improving biotech drugs. Better, cheaper and more effective drugs to combat cancer, arthritis and many other disorders.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| James C Lee, DPM 75 Remittance Dr Dept 6008, Chicago, IL 60675-6008 Ph: (562) 282-1419 | James C Lee, DPM 5475 E La Palma Ave, Ste 208, Anaheim, CA 92807-6009 Ph: (714) 777-0750 |
News Archive
Merck & Co., Inc. today announced financial results for the first quarter of 2010. The company reported non-GAAP (generally accepted accounting principles) earnings per share (EPS) for the first quarter of $0.83, which excludes purchase accounting adjustments, merger-related expenses and restructuring costs, as well as a tax charge related to the recently enacted health care reform legislation. First-quarter GAAP EPS was $0.09.
Approximately $500,000 is available in federal American Recovery and Reinvestment Act funds to support a specialized training curriculum on the Mental Health Procedures Act of 1976 for judges, law enforcement, psychologists, social workers and other professionals in the criminal justice system.
Z-Medica Corporation, a medical device company developing innovative hemostatic agents, today announced that it has signed exclusive distribution agreements with Vingmed AB and Mediplast AB, two leading Swedish medical device distributors, for distribution of its QuikClot line of hemostatic agents in Sweden, Denmark and Norway for the first time.
Researchers from the University of Copenhagen have discovered a way of improving biotech drugs. Better, cheaper and more effective drugs to combat cancer, arthritis and many other disorders.
› Verified 3 days ago
B Richard Burke, DPM FACFAS Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1761 W Romneya Dr, # E, Anaheim, CA 92801 Phone: 714-991-3333 Fax: 714-991-6059 | |
Kiarash Bakhaj Inc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 408 S Beach Blvd Ste 102, Anaheim, CA 92804 Phone: 714-204-8766 | |
Matthew M Do. Dpm, A Professional Corporation Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 934 S Euclid St, Anaheim, CA 92802 Phone: 714-533-3668 Fax: 714-533-3669 | |
Thrive Foot And Ankle Inc. Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 5475 E La Palma Ave Ste 208, Anaheim, CA 92807 Phone: 909-464-2008 Fax: 909-287-7705 | |
Miss Diana Le, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1011 W La Palma Ave, Ste 100, Anaheim, CA 92801 Phone: 714-774-1550 | |
Angela Wang, D.P.M. Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1761 W Romneya Dr, Anaheim, CA 92801 Phone: 714-991-3333 | |
Jacob R. Jensen, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 6200 E Canyon Rim Rd Ste 111e, Anaheim, CA 92807 Phone: 714-974-3338 Fax: 714-974-7683 |